Search | VHL Regional Portal

Support U.S. research during COVID-19.

Crow, Michael M; Alger, Jonathan; Amiridis, Michael; Assanis, Dennis; Barron, Eric; Becker, Mark P; Blank, Rebecca M; Block, Gene D; Bollinger, Lee C; Brown, Robert A; Burwell, Sylvia M; Cassidy, C Michael; Clements, James P; Currall, Steven; DeGioia, John J; Frenk, Julio; Fuchs, W Kent; Gabel, Joan T A; Gallagher, Patrick D; Gee, E Gordon; Isaacs, Eric; Jacobs, Lloyd A; Jahanian, Farnam; Jenkins, John; Johnson, Kristina M; Kanter, Martha; Kearns, Paul K; Kennedy, Mark; Khosla, Pradeep K; Leshin, Laurie; Lovell, Michael; May, Gary S; Morehead, Jere; Myers, Richard B; Proenza, Luis M; Rose, Clayton; Rudd, M David; Sands, Timothy D; Schlissel, Mark S; Stephens, Elisa; Stroble, Elizabeth; Subbaswamy, Kumble; Tripathi, Satish; Watkins, Ruth; Weinberg, Adam; Wilcox, Kim; Wince-Smith, Deborah; Wintersteen, Wendy; Woodson, W Randolph; Zimmer, Robert J.

Science ; 370(6516): 539-540, 2020 Oct 30.

Article in English | MEDLINE | ID: mdl-33122376

Subject(s)

Biomedical Research/economics , Biomedical Research/trends , Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , Universities , Betacoronavirus , COVID-19 , Financing, Government , Humans , Pandemics , SARS-CoV-2

Nanotechnology and society. New insights into public perceptions.

Currall, Steven C.

Nat Nanotechnol ; 4(2): 79-80, 2009 Feb.

Article in English | MEDLINE | ID: mdl-19197302

Subject(s)

Data Collection/trends , Nanotechnology , Public Opinion , Humans , Information Dissemination/methods , Nanotechnology/education , Perception , Propaganda

What drives public acceptance of nanotechnology?

Currall, Steven C; King, Eden B; Lane, Neal; Madera, Juan; Turner, Stacey.

Nat Nanotechnol ; 1(3): 153-5, 2006 Dec.

Article in English | MEDLINE | ID: mdl-18654170

ABSTRACT

How do the risks and benefits of nanotechnology, as viewed by the public, compare with those associated with other technologies such as genetically modified organisms, stem cells, biotechnology and nuclear power? And when deciding to use a specific nanotechnology product, will consumers consider the risks, the benefits, or both? We report the first large-scale empirical analyses of these questions.

Subject(s)

Nanostructures/adverse effects , Nanotechnology/trends , Public Opinion , Risk Assessment/methods , Humans , Internationality , Nanostructures/administration & dosage , Risk Factors

Subject(s)

Subject(s)

ABSTRACT

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL